Deadline Date: December 31, 2026
The Biotechnology Industry Research Assistance Council has launched the PCP Fund to support Indian startups in accelerating market launch, pilot-market validation, and large-scale commercialization of biotechnology products and technologies.
The programme focuses on biotechnology products and technologies developed by Indian startups that are nationally relevant and have reached Technology Readiness Level (TRL) 7 or above. The fund aims to support products that are market-ready, including those not previously developed with BIRAC funding, to prepare for commercial launch, validate in targeted markets, and scale operations.
BIRAC has been promoting product and technology development by Indian startups through multiple funding schemes such as BIG, BIPP, SBIRI, PACE, IIPME, and SPARSH, as well as partnership programs like Grand Challenges India, National Biopharma Mission, WISH, and the DBT-BIRAC biomanufacturing initiative, along with innovation awards such as TiE Winner. These programs support technology maturation up to pre-commercialization, continuously monitoring progress on the BIRAC-TRL scale from 1 to 9.
The PCP Fund addresses the gap in financing for market-ready products, providing support for pilot-market validation, large-scale commercialization, and preparing the ground for a market launch. Eligible applicants are Indian startups incorporated within 10 years from the completion of each call. Applicants must have at least 51% Indian shareholding, certified by a CA or CS with UDIN, and shareholders must hold valid Indian citizenship and passports.
For more information, visit BIRAC.
